EUVIMEDEUVIMED entdecken
Crossref

Albumin-Based MUC13 Peptide Nanomedicine Suppresses Liver Cancer Stem Cells via JNK-ERK Signaling Pathway-Mediated Autophagy Inhibition

Fen Sun, Zongyao Ding, Fengying Shao, Xiaoyang Gao, Haina Tian, Xiao Zhang, Huaqing Chen, Changlong Wang iD

ACS Applied Materials & Interfaces · 2024

DOI: 10.1021/acsami.4c06034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2024. Verfasst von Fen Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an 271016, China. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Autophagy, Liver Neoplasms, MAP Kinase Signaling System. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Taishan Scholar Project of Shandong Province, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Stem CellsAutophagyLiver NeoplasmsMAP Kinase Signaling SystemPeptidesNanomedicineHumansAnimalsMiceCarcinoma, HepatocellularAntineoplastic AgentsAlbuminsMice, NudeCell Line, TumorMice, Inbred BALB CCell Proliferation

Stichwörter der Autor:innen

albuminliver cancer stem cellsnanomaterialspeptide-based nanomedicinetargeted delivery

Substanzen

PeptidesAntineoplastic AgentsAlbumins

Autor:innen und Institutionen

  • School of Life Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an 271016, China.
  • Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250117, China.
  • School of Life Sciences, Tsinghua University, Beijing 100084, China.
  • State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China.
  • Key Laboratory of Biopharmaceutical Preparation and Delivery, Chinese Academy of Sciences, Beijing 100190, China.
  • School of Chemical Engineering, University of Chinese Academy of Sciences, Beijing 100049, China.

ORCID-Profile: Changlong Wang

Förderung

  • Taishan Scholar Project of Shandong Province
  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province
  • Youth Innovation Team Program of Colleges and Universities in Shandong Province
  • Talent Introduction Project of Shandong First Medical University

Zitieren

APA

Sun, F., Ding, Z., Shao, F., Gao, X., Tian, H., Zhang, X., Chen, H., & Wang, C. (2024). Albumin-Based MUC13 Peptide Nanomedicine Suppresses Liver Cancer Stem Cells via JNK-ERK Signaling Pathway-Mediated Autophagy Inhibition. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c06034

Vancouver

Sun F, Ding Z, Shao F, Gao X, Tian H, Zhang X, et al. Albumin-Based MUC13 Peptide Nanomedicine Suppresses Liver Cancer Stem Cells via JNK-ERK Signaling Pathway-Mediated Autophagy Inhibition. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c06034

BibTeX
@article{Sun2024,
  author = {Sun, Fen and Ding, Zongyao and Shao, Fengying and Gao, Xiaoyang and Tian, Haina and Zhang, Xiao and Chen, Huaqing and Wang, Changlong},
  title = {Albumin-Based MUC13 Peptide Nanomedicine Suppresses Liver Cancer Stem Cells via JNK-ERK Signaling Pathway-Mediated Autophagy Inhibition},
  journal = {ACS Applied Materials & Interfaces},
  year = {2024},
  doi = {10.1021/acsami.4c06034}
}
Kostenlos starten →